TRT Monotherapy vs TRT + hCG
TRT alone suppresses the HPG axis, reducing endogenous testosterone production and testicular volume. Adding hCG preserves intratesticular testosterone signaling, testicular volume, and a fertility window. Selection is provider-reviewed against fertility goals, cost, and biomarker response.
TRT monotherapy is appropriate when fertility preservation is not a candidate priority and testicular preservation is acceptable.
Explore pathwayTRT + hCG is the provider-reviewed pathway when fertility, testicular volume, or HPG-axis preservation matter to the candidate.
Explore pathwayEducational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.
Frequently asked
Does hCG fully preserve fertility?
It preserves intratesticular testosterone and spermatogenesis better than TRT alone, but does not guarantee fertility.
When is hCG added?
At baseline for fertility-focused candidates, or later if testicular atrophy becomes a concern.
Take the optimization assessment.
The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.
Begin assessment